We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nanoparticle and Snake Venom Help Discover Disease-Causing Proteins

By Biotechdaily staff writers
Posted on 22 Mar 2007
A complex molecule and snake venom may provide researchers with a more reliable method of diagnosing human diseases and developing new drugs. More...


Purdue University (Lafayette, IN, USA) scientists bound a complex nanomolecule, called a dendrimer, to a glowing identification tag that was delivered to specific proteins in living venom cells from a rattlesnake. The scientists aim was to find a better way to ascertain the presence, concentration, and function of proteins involved in disease processes. They also hoped that the new method will facilitate better, more efficient diagnosis in living cells and patients.

Most diagnostic methods use minute dead blood or tissue cell samples in a laboratory dish, said Dr. Andy Tao, a Purdue biochemist and senior author of the study. Because molecular interactions and protein functions are disturbed when samples are collected, scientists cannot obtain an accurate picture of biochemical mechanisms related to illnesses such as cancer and heart disease.

Dr. Tao and his research team used dendrimers because they can pass through cell walls efficiently with little disturbance to the cells and then label specific proteins with isotopic tags while cells are still alive. This allows the scientists to determine the activities of proteins that play roles in specific diseases. Proteins carry genetic messages throughout the cell causing biochemical changes that can determine whether a cell behaves normally or abnormally. Proteins also are important in directing immune responses.

The Purdue scientists reported on their new strategy to discover proteins and protein levels, called soluble polymer-based isotopic labeling (SoPIL), in the February 2007 issue of the journal Chemical Communications.

The problem with the current method of using proteomics--protein profiling--is that we use very small sample amounts so sensitive that we can't effectively use existing technologies to study them, Dr. Tao said. In addition, to study a specific protein and its function, we want to preserve its natural environment and see where two molecules meet and what the interaction is when they bind. Taking small samples of blood, cells or tissue to study extracted proteins in laboratory dishes [damage] the sample and the natural environment is destroyed.

The dendrimers would carry one of the stable isotopic or fluorescent labels to identify the presence or absence of a protein that can be further developed for use as a disease indicator, or biomarker. Snake venom cells were used because they have a very high concentration of proteins similar to some found in human blood, Dr. Tao said. The proteins apparently are part of the biochemical process that affects blood clotting or hemorrhage. Understanding how the proteins behave could be useful in diagnosis and drug development and help determine predisposition to heart disease and cancer, and also be useful in diagnosis and drug development.


Related Links:
Purdue University

New
Gold Member
Aspiration System
VACUSAFE
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Thyroid Test
Anti-Thyroid EIA Test
New
HPV Molecular Test
BD Onclarity HPV Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Plasma pTau217 testing can predict future amyloid accumulation and cognitive decline in cognitively healthy older adults (photo courtesy of Shutterstock)

Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more

Industry

view channel
Image: Pathlight combines WGS and dPCR to identify and longitudinally track large‑scale genomic changes, known as structural variants (photo courtesy of SAGA Diagnositcs)

Roche Affiliate Expands MRD Portfolio with SAGA Acquisition

Foundation Medicine, Inc., an independent affiliate of Roche, announced plans to expand its monitoring portfolio with SAGA Diagnostics’ Pathlight, a personalized, tumor-informed molecular residual disease... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.